Pre-Clinical Evaluation of a Replication-Competent Recombinant Adenovirus Serotype 4 Vaccine Expressing Influenza H5 Hemagglutinin

BACKGROUND: Influenza virus remains a significant health and social concern in part because of newly emerging strains, such as avian H5N1 virus. We have developed a prototype H5N1 vaccine using a recombinant, replication-competent Adenovirus serotype 4 (Ad4) vector, derived from the U.S. military Ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Alexander, Jeff, Ward, Simone, Mendy, Jason, Manayani, Darly J., Farness, Peggy, Avanzini, Jenny B., Guenther, Ben, Garduno, Fermin, Jow, Lily, Snarsky, Victoria, Ishioka, Glenn, Dong, Xin, Vang, Lo, Newman, Mark J., Mayall, Tim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3281928/
https://www.ncbi.nlm.nih.gov/pubmed/22363572
http://dx.doi.org/10.1371/journal.pone.0031177

Ejemplares similares

Ejemplares similares